BioCorRx, Inc. Announces Agreement with Four Additional Wellness Centers in California and Illinois

Los Angeles, Sept. 9, 2015 (GLOBE NEWSWIRE) — BioCorRx, Inc. (BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, announces new distribution agreements to bring the Start Fresh Program into four additional wellness centers.  The agreements are part of the company’s continued focus to distribute its addiction treatment program to wellness centers nationally through a partnership with Myriad Medical Marketing (MMM).  The new centers are Wellness Institute of Illinois, Coastside Health and Medical Clinic, INC., Mazolewski OC Medical PC, and COR Medical Group. “We are pleased about the continued expansion of our addiction treatment program into these centers,” stated COO & interim CEO, Brady Granier.  “Many individuals already receiving care at these centers, as well as their friends and families, will now hear about our program from their trusted healthcare providers in their respective areas.  Those who are struggling with addiction to alcohol or opioids can soon receive private, out-patient care using the tools of our program in a familiar and convenient setting,” says GranierThe new clinic locations are:Wellness Institute of Illinois6119-B Northwest HwyCrystal Lake, Illinois 60014Coastside Health and Medical Clinic, INC. 1618 Sullivan Ave, #208Daly City, California 94015Mazolewski OC Medical PC9988 Hibert, Suite 100San Diego, California 92131COR Medical Group1405 W. Rancho Vista Blvd.Palmdale, CA 93551Visit BioCorRx, Inc.’s investor relations website to receive the most up to date company information.Click here to view Recent National Television Media on the BioCorRx YouTube ChannelClick here for company Facebook page for more stories and media coverageAbout BioCorRxBioCorRx, Inc. ® (OTCQB: BICX) is an addiction treatment and rehabilitation company offering a unique approach to the treatment of substance abuse addiction. The Start Fresh Program®, a Medication-assisted Treatment (MAT) program, consists of two components. The first component of the program consists of an outpatient implant procedure performed by a licensed physician. The implant delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one counseling program specifically tailored for the treatment of alcoholism and other substance abuse addictions. Clinic reports show that the treatment program can be successful for individuals who complete the program. For more information on BICX, visit www.BioCorRx.comSafe Harbor StatementThe information in this release includes forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.Investor Relations, Inc.